Casey Woodring
Stock Analyst at JP Morgan
(0.39)
# 4,104
Out of 4,911 analysts
33
Total ratings
20%
Success rate
-20.32%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $186.56 | -19.60% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $27.23 | -8.19% | 4 | Apr 21, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $177.46 | -7.02% | 7 | Feb 20, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $66.54 | +41.27% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $51.86 | +7.25% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.35 | +79.10% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $16.37 | +40.54% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $12.31 | +46.22% | 2 | Jan 23, 2023 |
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $186.56
Upside: -19.60%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $27.23
Upside: -8.19%
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $177.46
Upside: -7.02%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $66.54
Upside: +41.27%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $51.86
Upside: +7.25%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.35
Upside: +79.10%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $16.37
Upside: +40.54%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $12.31
Upside: +46.22%